Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

The company said that its applications can be extended to individuals affected by ALS, stroke, spinal cord injury, cerebral ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECG TM software platform has ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...